Related Experiment Video
Updated: Jul 18, 2026
08:23
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Nitric oxide: emerging concepts about its use in cell-based therapies
Silvia Brunelli1, Patrizia Rovere-Querini, Clara Sciorati
1University of Milano-Bicocca, Department of Experimental, Environmental Medicine and Medical Biotechnology, 20052 Monza, Italy.
Expert Opinion on Investigational Drugs
|December 13, 2006
Summary
Regenerative medicine uses cell therapies to repair tissues. This review explores novel cell-based vaccines and stem cells, highlighting challenges and potential solutions using nitric oxide (NO) for enhanced therapies.
Area of Science:
- Regenerative Medicine
- Cell Therapy
- Biomedical Engineering
Background:
- Cell-based therapies are crucial for restoring damaged tissues and organs.
- Established methods include bone marrow and pancreatic islet cell transplantation.
- Emerging cell therapies, such as cell-based vaccines and stem cells, show significant promise.
Purpose of the Study:
- To review recent advancements in experimental cell-based therapeutic approaches.
- To identify and discuss the drawbacks of novel cell therapies.
- To explore the potential of nitric oxide (NO) in overcoming these limitations.
Main Methods:
- Focus on dendritic cell vaccines for cancer treatment.
- Focus on mesoangioblast stem cells for muscular dystrophies.
- Review of combined therapies involving NO-releasing drugs and cell delivery.
Main Results:
- Dendritic cell vaccines show promise in tumor treatment.
- Mesoangioblasts offer potential for muscular dystrophy repair.
- Nitric oxide (NO) may enhance cell therapy efficacy and overcome delivery challenges.
Conclusions:
- Novel cell therapies, including dendritic cell vaccines and mesoangioblasts, represent promising regenerative medicine strategies.
- Addressing the drawbacks of these therapies is essential for clinical translation.
- The integration of nitric oxide (NO)-releasing agents with cell delivery offers a viable approach to improve therapeutic outcomes.
More Related Videos
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:21Paracrine Signaling
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...